Viewing Study NCT00786851


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT00786851
Status: COMPLETED
Last Update Posted: 2016-08-17
First Post: 2008-11-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module